Merck (MRK)
AI-powered earnings call analysis for Merck. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.
Subscribe
Subscribe
Get Episode Notifications
Get an email when new Merck earnings episodes are released.
Next Episode
Merck earnings call scheduled for Oct 29, 2026 (before market open)
New episode expected Oct 30, 2026
Latest Episode
Q2 2026 Earnings
6:45 • 8/12/2026
All Episodes
Q2 2026 Earnings
6:45Merck delivered Q2 revenue of $16.6B (+5% YoY) with raised full-year guidance to $66.3-67.3B, driven by KEYTRUDA strength, new launches, and multiple clinical wins including sac-TMT Phase III positivity.
Q1 2026 Earnings
7:04Merck delivered 5% Q1 revenue growth to $16.3B driven by oncology and animal health strength, raised 2026 guidance despite a $9B Cidara acquisition charge, and positioned 20+ new launches as major growth drivers with $70B+ commercial potential by mid-2030s.
Q4 2025 Earnings
7:19AI-generated analysis of MRK's Q4 2025 earnings call.
